Jump Main Menu. Go directly to the main content

Sección de idiomas

EN

Fin de la sección de idiomas

Sección de utilidades

Calendar

Fin de la sección de utilidades

Secondary menu End of secondary menu

Research projects

Start of main content

Search for differential genetic markers between two different types of response to the same allergenic exposure: tolerance versus sensitisation

14th national competition for scientific and technical research

Genetic and pharmacogenetic markers

Senior Researcher : Blanca Cárdaba Olombrada

More information

Research Centre or Institution : Fundación Jiménez Díaz. Madrid

Abstract

The main purpose of this project is to determine why, in the presence of the same antigenic stimulus, some patients are affected (they become allergic) and others are not, taking advantage of the current possibility of simultaneously analysing the expression of nearly all genes (by "microarray" analysis) at different times during the environmental exposure. As our specific model, we have chosen the allergy to olive pollen, not only because of our experience in this field, but also because it is one of the most significant causes of pollinosis in the Mediterranean region and, after Gramineae, the second most common in Spain (the first in some regions, such as southern Spain). We are endeavouring to define molecular mechanisms that regulate the allergic response to this pollen, comparing the genic expression, in low and high environmental exposure conditions, of 5 groups of subjects: a) tolerant, b) asymptomatic or subclinical, c) allergy sufferers, not sensitised to olive pollen, d) sensitised to olive pollen, untreated, and e) sensitised to olive pollen, treated. The results of this work, apart from providing additional knowledge on the etiopathogeny of these kinds of responses, could be extremely useful in defining allergic response risk and/or prevention markers, as well as establishing regulating mechanisms that could improve the current immune therapy actions and open new horizons for the design of future specific treatments.

  • Activities related
  • Projects related
  • News related
  • Publications related

see all

End of main content